FDA label

What is Ozempic used for?

Ozempic contains semaglutide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease; to reduce the risk of sustained eGFR decline, end-stage k...”

Run it in Rivvi

Which 2027 plans near you dropped or restricted Ozempic?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Ozempic, injection, solution

Indications and Usage, quoted from the label by Novo Nordisk Pharmaceutical Industries, LP (NDA209637). Cross-references to other label sections are left out.

OZEMPIC is indicated:

  • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease.
  • to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease.

Source: DailyMed label, set id adec4fd2-6858-4c99-91d4-531f5f2a2d79, version 20, effective June 1, 2026. NDC 0169-4130, one of 6 listings for this product.

Ozempic, tablet

Indications and Usage, quoted from the label by Novo Nordisk Pharmaceutical Industries, LP (NDA213051). Cross-references to other label sections are left out.

RYBELSUS and OZEMPIC tablets are indicated:

  • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events.

Source: DailyMed label, set id 27f15fac-7d98-4114-a2ec-92494a91da98, version 14, effective January 30, 2026. NDC 0169-1704, one of 3 listings for this product.

Questions

What is Ozempic used for?

The FDA label says: “OZEMPIC is indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease; to reduce the risk of sustained eGFR decline, end-stage k...”

What drug class is Ozempic?

FDA lists semaglutide in the GLP-1 Receptor Agonist established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Ozempic

Try it on your own data today.

Free to start. Most teams are using it the same day.